Propecia Lawsuit Update: Merck Named in 265 Lawsuits Alleging Propecia Sexual Dysfunction, Bernstein Liebhard LLP Reports

Share Article

Bernstein Liebhard LLP is actively evaluating Propecia lawsuits on behalf of men who suffered persistent sexual dysfunction allegedly due to Propecia.

Bernstein Liebhard LLP | Consumer Injury Lawyers
We continue to hear from men who have suffered persistent sexual side effects after they stopped using Propecia. It’s not surprising that plaintiffs continue to file Propecia sexual dysfunction lawsuits in these litigations.

Merck & Co. recently reported that it has been named in more than 200 Propecia lawsuits alleging the medication caused men to suffer persistent sexual side effects following cessation of treatment, Bernstein Liebhard LLP reports. According to the company’s 3rd quarter earnings report issued on November 9, 2012, 265 Propecia sexual dysfunction lawsuits filed by 415 plaintiffs were pending in New York federal court and New Jersey Superior Court as of September 30, 2012.

The federal claims have been consolidated in a multidistrict litigation in the Eastern District of New York (Propecia (Finasteride) Product Liability Litigation – MDL No. 2331). A consolidated litigation has also been established for Propecia lawsuits in New Jersey Superior Court, Middlesex County (In Re: Propecia Litigation, No. 623, N.J. Super. Ct).*

“We continue to hear from men who have suffered persistent sexual side effects after they stopped using Propecia. It’s not surprising that plaintiffs continue to file Propecia sexual dysfunction lawsuits in these litigations,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The firm is actively investigating Propecia lawsuits on behalf of men who experienced long-lasting sexual side effects, allegedly due to Propecia.

Propecia Sexual Dysfunction
Propecia is a prescription medicine that is used to treat male pattern baldness. In April 2012, the U.S. Food & Drug Administration (FDA) announced that the Propecia label would be updated to advise that some men had experienced problems with libido, ejaculation and orgasms that continued after use of the drug was ended. Additional information was also added to the Propecia label describing reports of male infertility and poor semen quality that normalized or
improved after use of the drug was stopped.**

A July 2012 study in the Journal of Sexual Medicine found that Propecia sexual dysfunction may last months after patients stop using the drug.*** A survey of men who suffered Propecia sexual side effects published in the Journal of Clinical Psychiatry in August 2012 found that 75 percent reported symptoms of depression. Forty-four percent reported suicidal thoughts.****

Victims of Propecia sexual dysfunction may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. The lawyers at Bernstein Liebhard LLP are currently evaluating and investigating potential Propecia lawsuits. For more information about Propecia sexual dysfunction and depression, visit, or call (877) 779-1414.


About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website